Weitere Formate
Softcover - 9783319876283
160,49 €
Autorenfreundlich Bücher kaufen?!
Beschreibung
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Details
| Verlag | Springer International Publishing |
| Ersterscheinung | 10. November 2017 |
| Maße | 23.5 cm x 15.5 cm |
| Gewicht | 682 Gramm |
| Format | Hardcover |
| ISBN-13 | 9783319637563 |
| Seiten | 331 |
Schlagwörter
Herstellerinformationen
Bekannt durch
